title: Conversion from cyclosporine: status after five years.
authors.affiliation: Department of Medicine/Nephrology, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina 27103.
authors.forename: B I
authors.initials: BI
authors.lastname: Freedman
authors.forename: A B
authors.initials: AB
authors.lastname: Tuttle
authors.forename: W B
authors.initials: WB
authors.lastname: Lorentz
authors.forename: M C
authors.initials: MC
authors.lastname: Browning
authors.forename: J H
authors.initials: JH
authors.lastname: Meredith
authors.forename: J M
authors.initials: JM
authors.lastname: Burkart
authors.forename: P L
authors.initials: PL
authors.lastname: Adams
mesh_terms: D000328:Adult; D001379:Azathioprine / Q000008:administration & dosage*; D003524:Cyclosporins / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006084:Graft Rejection; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D016030:Kidney Transplantation / Q000379:methods*; D008297:Male; D013256:Steroids / Q000008:administration & dosage; D013997:Time Factors
chemical_list: D003524:Cyclosporins; D013256:Steroids; D001379:Azathioprine